CCHT(000661.SZ)

Last Updated 00:00:00
longbridge loading
Company Encyclopedia
View More
name
CCHT
000661.SZ
Changchun High-Tech Industry (Group) Co., Ltd., together with its subsidiaries, researches, develops, manufactures, and sells biopharmaceuticals and traditional Chinese medicines products in China. The company offers recombinant human growth hormone injection; recombinant human follicle stimulating hormone for injection; herpes zoster vaccines; live attenuated varicella vaccine; freeze-dried nasal spray live attenuated influenza; xueshuanxinmaining tablet; and yinhuamiyanling tablet. It also develops real estate properties. The company was founded in 1993 and is based in Changchun, China.
2.805 T
000661.SZMarket value -Rank by Market Cap -/-

Financial Score

19/05/2026 Update
C
PharmaceuticalsIndustry
Industry Ranking70/215
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreC
    • ROE-0.18%D
    • Profit Margin-0.36%D
    • Gross Margin77.95%A
  • Growth ScoreE
    • Revenue YoY-12.14%E
    • Net Profit YoY-101.91%E
    • Total Assets YoY-2.93%D
    • Net Assets YoY-5.37%D
  • Cash ScoreE
    • Cash Flow Margin-3165.08%E
    • OCF YoY-12.14%E
  • Operating ScoreC
    • Turnover0.37C
  • Debt ScoreA
    • Gearing Ratio18.30%A

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Changchun High-tech Subsidiary Receives FDA Orphan Drug Designation for GenSci128, Targeting Gastric Cancer

    CoinLive·
    SZ
    000661
    +0.92%
    CoinLive·
    SZ
    000661
    +0.92%

    GenSci128 Receives Orphan Drug Designation for Pancreatic Cancer Treatment

    CoinLive·
    SZ
    000661
    +0.92%
    CoinLive·
    SZ
    000661
    +0.92%

    CCHT's "New Drug for Treating Male Children's Developmental Disorders" Sparks Stock Price Surge; Company Responds: Project is Still in Early Stages

    Wallstreetcn·
    SZ
    000661
    +0.92%
    Wallstreetcn·
    SZ
    000661
    +0.92%

    "Northeast Medicine Mogul" Transforms into Innovative Pharmaceuticals

    Wallstreetcn·
    SZ
    000661
    +0.92%
    Wallstreetcn·
    SZ
    000661
    +0.92%

    Zhitong A-share lock-up release overview | November 4

    Zhitong·
    SH
    600415
    +5.72%
    SZ
    002643
    +0.28%
    SZ
    002864
    +0.03%
    Zhitong·
    SH
    600415
    +5.72%
    SZ
    002643
    +0.28%
    SZ
    002864
    +0.03%
    © 2026 Longbridge｜Disclaimer